93 results
DEFM14A
IMGN
Immunogen, Inc.
2 Jan 24
Proxy related to merger
4:26pm
, customer, distributor, consumer and supplier lists and data, clinical and technical data, operational data, engineering information, invention and technical
PREM14A
IMGN
Immunogen, Inc.
21 Dec 23
Preliminary proxy related to merger
4:52pm
or confidential information, including trade secrets, know-how, customer, distributor, consumer and supplier lists and data, clinical and technical data
DEFA14A
EX-2.1
IMGN
Immunogen, Inc.
30 Nov 23
Additional proxy soliciting materials
4:07pm
trade secrets, know-how, customer, distributor, consumer and supplier lists and data, clinical and technical data, operational data, engineering
8-K
EX-2.1
IMGN
Immunogen, Inc.
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
4:05pm
trade secrets, know-how, customer, distributor, consumer and supplier lists and data, clinical and technical data, operational data, engineering
8-K
EX-99.1
78zzw22nya9fu8 h3bd
18 Dec 20
Other Events
4:16pm
10-KT
l0ux0l654
3 Mar 17
Annual report (with FYE transition)
12:00am